For years, pharma launch success was judged by a single metric: performance in the first 12 months. That benchmark no longer reflects reality. Today’s commercial environment has fundamentally reshaped what launch success looks like. Payer control has intensified. Provider adoption is slower. Patients are more involved in treatment decisions — yet face greater access and […]










